Drug-Resistant, Epilepsy

Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight

17.03.2026 - 23:17:28 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | CA00765C1086 | DRUG-RESISTANT | boerse | 68752630 |